# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5241756 | F | Antimalarial activity against chloroquine resistant Plasmodium falciparum FcB1 Colombia | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
2. | ALA5241757 | F | Antimalarial activity against chloroquine resistant Plasmodium falciparum FcR3 Gambia | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
3. | ALA5241758 | F | Antimalarial activity against chloroquine resistant Plasmodium falciparum PaloAlto | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
4. | ALA5241759 | F | Antimalarial activity against chloroquine resistant Plasmodium falciparum W2 | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
5. | ALA5241760 | F | Antimalarial activity against chloroquine resistant Plasmodium falciparum FcM29 Cameron | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
6. | ALA5241761 | F | Antimalarial activity against chloroquine sensitive Plasmodium falciparum D6 | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
7. | ALA5241762 | F | Antimalarial activity against chloroquine sensitive Plasmodium falciparum F32 | Plasmodium falciparum | 3 | organism-based format | Scientific Literature | ||
8. | ALA5241763 | F | Antimalarial activity against chloroquine resistant Plasmodium vinckei infected in po dosed swiss mouse assessed as reduction in parasitemia | Plasmodium vinckei | 3 | organism-based format | Scientific Literature | ||
9. | ALA5241764 | F | Antimalarial activity against chloroquine sensitive Plasmodium vinckei petteri infected in po dosed swiss mouse assessed as reduction in parasitemia | Plasmodium vinckei petteri | 3 | organism-based format | Scientific Literature | ||
10. | ALA5241765 | F | Antimalarial activity against erythrocytic stage chloroquine sensitive Plasmodium falciparum 3D7 infected in mouse assessed as reduction in parasitemia at 32 mg/kg/day, po qd measured after 4 days by Giemsa staining based analysis relative to control | Plasmodium falciparum | 1 | organism-based format | Scientific Literature | ||
11. | ALA5241766 | F | Antimalarial activity against erythrocytic stage chloroquine sensitive Plasmodium falciparum W2 infected in mouse assessed as reduction in parasitemia at 32 mg/kg/day, po qd measured after 4 days by Giemsa staining based analysis relative to control | Plasmodium falciparum | 1 | organism-based format | Scientific Literature | ||
12. | ALA5241767 | F | Antimalarial activity against erythrocytic stage chloroquine sensitive Plasmodium falciparum 3D7 infected in mouse assessed as reduction in parasitemia at 63 mg/kg/day, po qd measured after 4 days by Giemsa staining based analysis relative to control | Plasmodium falciparum | 1 | organism-based format | Scientific Literature | ||
13. | ALA5241768 | F | Antimalarial activity against erythrocytic stage chloroquine sensitive Plasmodium falciparum W2 infected in mouse assessed as reduction in parasitemia at 63 mg/kg/day, po qd measured after 4 days by Giemsa staining based analysis | Plasmodium falciparum | 1 | organism-based format | Scientific Literature | ||
14. | ALA5241769 | F | Antiplasmodial activity against chloroquine resistant Plasmodium falciparum by HRP2 ELISA analysis | Plasmodium falciparum | 3 | organism-based format | Scientific Literature |